Sodium Channel Blocker Relieves Acute Pain in Phase III Data Trials favor a first new class of pain drug in years Oct 22, 2024
MIND Diet and Cognitive Decline; Gene Therapy for Parkinson's; Curbing MS Fatigue News and commentary from the world of neurology and neuroscience Oct 22, 2024
Hearing Loss May Signal Early Parkinson's Disease Early interventions with hearing aids attenuated the risk Oct 21, 2024
Daily Oral Edaravone for ALS No Better Than On/Off Regimen Changes in CAFS, ALSFRS-R scores comparable at 48 weeks Oct 21, 2024
Stroke Prevention Guideline Adds Recs for GLP-1 Drugs, Gender-Affirming Care Recommendation updates also address social determinants of health Oct 21, 2024
Case Against Perioperative Beta-Blockers Grows Stronger Excess postoperative strokes, and accompanying racial disparities, tied to any beta-blocker use Oct 20, 2024
Myasthenia Gravis Patients May Use Less Steroids After Starting Efgartigimod Insurance claims data show lower glucocorticoid usage at 1 year Oct 20, 2024
Deep Neuromuscular Blockade Helps Keyhole Surgery, but Not Outcomes Per Se No impact on safety outcomes after laparoscopic surgery Oct 20, 2024
Sustained Disease Control in Adolescent Myasthenia Gravis With FcRn Blocker Nipocalimab plus standard of care reduced IgG and was well tolerated Oct 19, 2024
Gene Therapy Details Revealed in Duchenne Trial Differences between delandistrogene moxeparvovec and placebo emerge in secondary outcomes Oct 18, 2024
Stroke Survivors Still Prescribed a 'Concerning' Amount of Benzos Red flag in nationwide data despite improvement since 2013 Oct 17, 2024
Continuous Parkinson's Disease Therapy Wins FDA Nod Round-the-clock infusion delivers carbidopa and levodopa pro-drugs Oct 17, 2024
Kids' Neurodevelopment Appears Unharmed by Maternal COVID Infection Study may ease fears about potential neurodevelopmental effects of fetal COVID exposure Oct 17, 2024 video
Nipocalimab Shows Sustained Efficacy in Myasthenia Gravis Phase III trial met primary endpoint at 6 months Oct 16, 2024
Anti-CD19 Monoclonal Antibody Shows Positive Results in Myasthenia Gravis Topline phase III data show inebilizumab met primary endpoint Oct 15, 2024
Clonidine Comparable to Morphine for Infants With Opioid Withdrawal Randomized trial showed no significant differences in length of treatment, neurobehavioral scores Oct 15, 2024
Alzheimer's-Heparin Link; Two Phases of Alzheimer's Damage; Prion Disease Testing News and commentary from the world of neurology and neuroscience Oct 15, 2024
Millions of Aging Americans Are Facing Dementia by Themselves "I will not survive this in the end -- I know that," says one patient Oct 15, 2024
Alzheimer's Drug in Smaller Vial Sizes Could Save Medicare Hundreds of Millions Nearly 6% of lecanemab may be discarded each year Oct 14, 2024
Loneliness Tied to Alzheimer's and Dementia Risk Feeling lonely also linked with cognitive impairment that's not dementia, meta-analysis shows Oct 11, 2024
Kate Middleton's Post-Chemo Debut; CDC Probes Cancer Cluster; 15M Adults Have ADHD Health news and commentary gathered by Â鶹´«Ã½ staff Oct 11, 2024
Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk 10% of patients in trials leading to eli-cel's approval developed MDS or AML Oct 09, 2024
Some Cancers Occur More Frequently in Multiple Sclerosis Patients Bladder, brain, and cervical cancer risks were higher in people with MS Oct 09, 2024
Liberal Blood Transfusions Deliver Brain Function Benefit for the Critically Ill Fewer cerebral ischemic events also observed with care teams quicker to give blood Oct 09, 2024
One Way to Spot Early Cognitive Decline? Medicare Wellness Visits Annual evaluation tied to timelier mild cognitive impairment diagnoses Oct 09, 2024
How the Brain Clears Waste; Masked Benzodiazepine Taper; New Hope for PML News and commentary from the world of neurology and neuroscience Oct 08, 2024
Overdose Deaths Are Falling but the Mission Is Far From Accomplished We still don't know what's driving the trend, and numbers remain unacceptably high Oct 04, 2024
As #Mouthtape for Sleep Apnea Takes Off, Research Raises Concern for One Group Airflow deteriorated in one subset of patients when their mouths were kept closed Oct 03, 2024
'Significant Milestone' for Radionuclide Therapy in Refractory Meningioma Small study suggests large benefit for Lu-177 dotatate in intracranial disease Oct 02, 2024
Some Epilepsy Drugs Tied to Cardiovascular Events in Older People Link likely due to enzyme-inducing antiseizure medications Oct 02, 2024
Low-Dose Lithium Tested in Long COVID No benefit for brain fog or fatigue, but higher doses may have promise Oct 02, 2024
Hearing Loss-Cognition Link; Circadian Brain Changes; Repetitive Head Impact Markers News and commentary from the world of neurology and neuroscience Oct 01, 2024
Neurocognitive Side Effects of Brain Radiation Subside for Many, Analysis Shows In three trials, about 40% of patients with brain metastases recovered neurocognitive function Oct 01, 2024
AAP Releases First Guidance on Outpatient Opioid Prescribing for Youths Recommends a multimodal approach to treating acute pain, with use of opioids "when needed" Oct 01, 2024
Doctors Less Likely to Support Broader Access to Cannabis Than Pain Patients A majority of respondents were supportive of increasing education for providers, however Oct 01, 2024 video
Falling May Be a Harbinger of Dementia in Older Adults Injurious falls upped the risk of a new Alzheimer's or dementia diagnosis 1 year later Sep 30, 2024
Brett Favre's Parkinson's: 'Hell, I Wrote the Book on Head Trauma' What we know -- and don't know -- about pro football and brain disorders Sep 27, 2024
Former NFL QB's Dementia; Stem Cells Reverse Woman's Diabetes; More Free COVID Tests Health news and commentary gathered by Â鶹´«Ã½ staff Sep 27, 2024
NIH Neuroscience Leader Committed Research Misconduct, Agency Says Longtime NIA researcher investigated synaptic damage in neurodegenerative disorders Sep 26, 2024
Post-Stroke Fever Prevention Still Lacking in Clinical Benefit Temperature management device did result in less fever in the INTREPID trial Sep 25, 2024
